LT5015B - Biologinės medžiagos implantavimo palengvinimo įtaisas - Google Patents

Biologinės medžiagos implantavimo palengvinimo įtaisas Download PDF

Info

Publication number: LT5015B
Authority: LT; Lithuania
Prior art keywords: implantation; facilitating; biological material; material according; biological
Prior art date: 1998-12-15

Application number

LT2001062A

Other languages

English (en)

Lithuanian (lt)

Other versions

LT2001062A (en

Inventor

Rafael VALDEZ-GONZALEZ

Original Assignee

Universidad Nacional Autonoma De Mexico

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-15

Filing date

2001-06-13

Publication date

2003-04-25

1998-12-15 Priority claimed from MXPA/A/1998/010667A external-priority patent/MXPA98010667A/xx

2001-06-13 Application filed by Universidad Nacional Autonoma De Mexico filed Critical Universidad Nacional Autonoma De Mexico

2003-01-27 Publication of LT2001062A publication Critical patent/LT2001062A/xx

2003-04-25 Publication of LT5015B publication Critical patent/LT5015B/lt

Links

238000002513 implantation Methods 0.000 title claims abstract description 28
239000012620 biological material Substances 0.000 title claims description 22
239000003181 biological factor Substances 0.000 claims abstract description 23
239000000126 substance Substances 0.000 claims abstract description 6
210000003708 urethra Anatomy 0.000 claims abstract description 3
238000007789 sealing Methods 0.000 claims description 47
239000000463 material Substances 0.000 claims description 10
210000004153 islets of langerhan Anatomy 0.000 claims description 4
229920001436 collagen Polymers 0.000 claims description 3
238000004113 cell culture Methods 0.000 claims description 2
108090000623 proteins and genes Proteins 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims 4
239000003124 biologic agent Substances 0.000 claims 1
210000003238 esophagus Anatomy 0.000 claims 1
230000037431 insertion Effects 0.000 claims 1
238000003780 insertion Methods 0.000 claims 1
239000002244 precipitate Substances 0.000 claims 1
230000002792 vascular Effects 0.000 claims 1
206010012601 diabetes mellitus Diseases 0.000 abstract description 6
201000010099 disease Diseases 0.000 abstract description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
210000004204 blood vessel Anatomy 0.000 abstract description 4
210000004027 cell Anatomy 0.000 description 31
239000007943 implant Substances 0.000 description 12
238000000034 method Methods 0.000 description 12
238000011282 treatment Methods 0.000 description 12
230000007246 mechanism Effects 0.000 description 11
206010029113 Neovascularisation Diseases 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
235000015097 nutrients Nutrition 0.000 description 5
238000000926 separation method Methods 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
239000008103 glucose Substances 0.000 description 4
229920001343 polytetrafluoroethylene Polymers 0.000 description 4
239000004810 polytetrafluoroethylene Substances 0.000 description 4
230000002519 immonomodulatory effect Effects 0.000 description 3
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
108010036949 Cyclosporine Proteins 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
241000700159 Rattus Species 0.000 description 2
230000000712 assembly Effects 0.000 description 2
238000000429 assembly Methods 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
229960001265 ciclosporin Drugs 0.000 description 2
229930182912 cyclosporin Natural products 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000000302 ischemic effect Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
-1 polytetrafluoroethylene Polymers 0.000 description 2
239000000047 product Substances 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000012546 transfer Methods 0.000 description 2
LEKIODFWYFCUER-UHFFFAOYSA-N 2-methylidenebut-3-enenitrile Chemical compound C=CC(=C)C#N LEKIODFWYFCUER-UHFFFAOYSA-N 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
229930105110 Cyclosporin A Natural products 0.000 description 1
208000037408 Device failure Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
206010060872 Transplant failure Diseases 0.000 description 1
230000009471 action Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
238000011138 biotechnological process Methods 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
239000002775 capsule Substances 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000004035 construction material Substances 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000002989 hypothyroidism Effects 0.000 description 1
208000003532 hypothyroidism Diseases 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
239000002085 irritant Substances 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
238000011670 long-evans rat Methods 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
238000003754 machining Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
229960000951 mycophenolic acid Drugs 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
235000006286 nutrient intake Nutrition 0.000 description 1
238000011017 operating method Methods 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
210000004180 plasmocyte Anatomy 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
239000004576 sand Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
229910052719 titanium Inorganic materials 0.000 description 1
239000010936 titanium Substances 0.000 description 1
239000002699 waste material Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Oral & Maxillofacial Surgery (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Botany (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Cell Biology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Prostheses (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

LT2001062A 1998-12-15 2001-06-13 Biologinės medžiagos implantavimo palengvinimo įtaisas LT5015B (lt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
MXPA/A/1998/010667A MXPA98010667A (es)		1998-12-15	Procedimiento y dispositivo para favorecer el implante de material biologico

Publications (2)

Publication Number	Publication Date
LT2001062A LT2001062A (en)	2003-01-27
LT5015B true LT5015B (lt)	2003-04-25

Family

ID=19745068

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LT2001062A LT5015B (lt)	1998-12-15	2001-06-13	Biologinės medžiagos implantavimo palengvinimo įtaisas

Country Status (30)

Country	Link
US (1)	US6716246B1 (xx)
EP (1)	EP1435220B1 (xx)
JP (1)	JP3722698B2 (xx)
KR (1)	KR100502285B1 (xx)
CN (1)	CN1204854C (xx)
AT (1)	ATE336207T1 (xx)
AU (1)	AU772166B2 (xx)
BR (1)	BR9917048A (xx)
CA (1)	CA2355675C (xx)
CY (1)	CY1106264T1 (xx)
CZ (1)	CZ302458B6 (xx)
DE (1)	DE69932866T2 (xx)
DK (1)	DK1435220T3 (xx)
EA (1)	EA003119B1 (xx)
EE (1)	EE04802B1 (xx)
ES (1)	ES2270626T3 (xx)
HU (1)	HU226054B1 (xx)
IL (2)	IL143775A0 (xx)
IS (1)	IS2351B (xx)
LT (1)	LT5015B (xx)
LV (1)	LV12728B (xx)
NO (1)	NO318469B1 (xx)
NZ (1)	NZ512358A (xx)
PL (1)	PL191994B1 (xx)
PT (1)	PT1435220E (xx)
RO (1)	RO120313B1 (xx)
SI (1)	SI20847B (xx)
SK (1)	SK285392B6 (xx)
TR (1)	TR200101769T2 (xx)
WO (1)	WO2000035371A2 (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7399751B2 (en) *	1999-11-04	2008-07-15	Sertoli Technologies, Inc.	Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
CA2594492A1 (en)	1999-03-07	2000-09-14	Active Implants Corporation	Method and apparatus for computerized surgery
US20050265977A1 (en) *	1999-04-30	2005-12-01	Elliott Robert B	Xenotransplant for CNS therapy
DE60044431D1 (en) *	1999-04-30	2010-07-01	Neurotrophincell Pty Ltd	Xenotransplant für zns therapie
US20090047325A1 (en) *	1999-04-30	2009-02-19	Neurotrophincell Pty. Limited	Xenotransplant for cns therapy
US7122177B2 (en) *	2000-01-20	2006-10-17	Diabcell Pty Ltd.	Preparation and xenotransplantation of porcine islets
ES2386505T3 (es) *	2000-10-17	2012-08-22	Diatranz Otsuka Limited	Preparación y xenotrasplante de islotes de cerdo
EP1373609A1 (en) *	2001-03-26	2004-01-02	University College London	Method for forming hardened tubes and sheets
WO2003027270A1 (en) *	2001-09-28	2003-04-03	Diabcell Pty Limited	Growing xenotransplant material in culture
NZ515310A (en) *	2001-11-07	2004-08-27	Diabcell Pty Ltd	Methods of treatment and delivery modes
AU2003238760B2 (en) *	2003-06-24	2008-07-31	Diatranz Otsuka Limited	Porcine islets cultured with porcine sertoli cells for xenotransplantation
US20050118145A1 (en) *	2003-07-03	2005-06-02	Jannette Dufour	Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
CA2544726C (en)	2003-11-07	2018-06-26	University Of Connecticut	Artificial tissue systems and uses thereof
SMAP200700004A (it) *	2004-07-29	2007-02-28	Univ Miami	Dispositivo ibrido per terapie cellulari
JP4932832B2 (ja) *	2005-06-02	2012-05-16	アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ	血管予形成デバイスおよび関連する方法
NZ540597A (en) *	2005-06-08	2007-02-23	Neurotrophincell Pty Ltd	A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
US20090191167A1 (en) *	2006-07-28	2009-07-30	Sertocell Biotechnology (Us) Corp.	Adult sertoli cells and uses thereof
US8506636B2 (en)	2006-09-08	2013-08-13	Theken Spine, Llc	Offset radius lordosis
US8702684B2 (en)	2007-02-02	2014-04-22	University Of Miami	Therapeutic hybrid implantable devices
EP2180906B1 (fr) *	2007-08-31	2014-12-24	Synolyne Pharma	Prothese destinee a promouvoir la reconstruction in vivo d'un organe creux ou d'une partie d'organe creux
ES2932850T3 (es) *	2008-11-14	2023-01-27	Viacyte Inc	Encapsulación de células pancreáticas derivadas de células madre pluripotentes humanas
SG178565A1 (en)	2009-08-28	2012-04-27	Sernova Corp	Methods and devices for cellular transplantation
AU2014200845B2 (en) *	2009-08-28	2016-05-12	Sernova Corporation	Methods and Devices for Cellular Transplantation
AU2016203097A1 (en) *	2009-08-28	2016-06-02	Sernova Corporation	Methods And Devices For Cellular Transplantation
MX2010013135A (es) *	2010-11-30	2012-05-31	Val De Bio S De R L De C V	Procedimiento y dispositivo mejorados para favorecer el trasplante de material biológico.
ES2637640T3 (es)	2011-04-29	2017-10-16	Converge Biotech Inc.	Recubrimiento conformal de células para inmunoaislamiento
CN103110436B (zh) *	2013-03-11	2015-05-13	刘亚平	一种椎体内神经占位器
US10405961B2 (en)	2013-03-14	2019-09-10	Cell and Molecular Tissue Engineering, LLC	Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en)	2013-03-14	2018-11-20	Cell and Molecular Tissue Engineering, LLC	Coated sensors, and corresponding systems and methods
CN110960733B (zh) *	2019-12-19	2022-03-15	广州市妇女儿童医疗中心	一种用于植入受试者皮下组织的新血管构建体及其制备方法
AU2021263388A1 (en)	2020-04-28	2023-01-05	University Of Miami	Conformal coating of cells for immunoisolation
WO2025240590A1 (en) *	2024-05-14	2025-11-20	University Of Miami	Vascularized device and method for islet transplantation without chronic immunosuppression

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5569462A (en)	1993-09-24	1996-10-29	Baxter International Inc.	Methods for enhancing vascularization of implant devices
US5614205A (en)	1992-02-24	1997-03-25	Encelle, Inc.	Bioartificial endocrine device
US5725854A (en)	1994-04-13	1998-03-10	Research Corporation Technologies, Inc.	Methods of treating disease using sertoli cells an allografts or xenografts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5575815A (en) *	1988-08-24	1996-11-19	Endoluminal Therapeutics, Inc.	Local polymeric gel therapy
US5100392A (en) *	1989-12-08	1992-03-31	Biosynthesis, Inc.	Implantable device for administration of drugs or other liquid solutions
US5492826A (en) *	1993-12-10	1996-02-20	William Beaumont Hospital	Apparatus and method for seeding endothelial cells
US5741334A (en) *	1995-06-07	1998-04-21	Circe Biomedical, Inc.	Artificial pancreatic perfusion device
US6136296A (en) *	1997-04-25	2000-10-24	The Procter & Gamble Company	Personal care compositions
US6117166A (en) *	1997-10-27	2000-09-12	Winston; Thomas R.	Apparatus and methods for grafting blood vessel tissue

1999
- 1999-12-14 SK SK829-2001A patent/SK285392B6/sk unknown
- 1999-12-14 NZ NZ512358A patent/NZ512358A/xx not_active IP Right Cessation
- 1999-12-14 IL IL14377599A patent/IL143775A0/xx active IP Right Grant
- 1999-12-14 EP EP99961495A patent/EP1435220B1/en not_active Expired - Lifetime
- 1999-12-14 CN CNB998145017A patent/CN1204854C/zh not_active Expired - Fee Related
- 1999-12-14 SI SI9920095A patent/SI20847B/sl not_active IP Right Cessation
- 1999-12-14 CA CA002355675A patent/CA2355675C/en not_active Expired - Fee Related
- 1999-12-14 TR TR2001/01769T patent/TR200101769T2/xx unknown
- 1999-12-14 US US09/868,103 patent/US6716246B1/en not_active Expired - Lifetime
- 1999-12-14 ES ES99961495T patent/ES2270626T3/es not_active Expired - Lifetime
- 1999-12-14 EA EA200100664A patent/EA003119B1/ru not_active IP Right Cessation
- 1999-12-14 HU HU0203247A patent/HU226054B1/hu not_active IP Right Cessation
- 1999-12-14 PL PL352559A patent/PL191994B1/pl unknown
- 1999-12-14 JP JP2000587693A patent/JP3722698B2/ja not_active Expired - Fee Related
- 1999-12-14 EE EEP200100325A patent/EE04802B1/xx not_active IP Right Cessation
- 1999-12-14 AT AT99961495T patent/ATE336207T1/de active
- 1999-12-14 BR BR9917048-5A patent/BR9917048A/pt not_active IP Right Cessation
- 1999-12-14 KR KR10-2001-7007368A patent/KR100502285B1/ko not_active Expired - Fee Related
- 1999-12-14 DK DK99961495T patent/DK1435220T3/da active
- 1999-12-14 AU AU18057/00A patent/AU772166B2/en not_active Ceased
- 1999-12-14 CZ CZ20012158A patent/CZ302458B6/cs not_active IP Right Cessation
- 1999-12-14 WO PCT/MX1999/000039 patent/WO2000035371A2/es not_active Ceased
- 1999-12-14 PT PT99961495T patent/PT1435220E/pt unknown
- 1999-12-14 DE DE69932866T patent/DE69932866T2/de not_active Expired - Lifetime
- 1999-12-14 RO ROA200100681A patent/RO120313B1/ro unknown
2001
- 2001-06-13 LT LT2001062A patent/LT5015B/lt not_active IP Right Cessation
- 2001-06-14 IS IS5968A patent/IS2351B/is unknown
- 2001-06-14 NO NO20012942A patent/NO318469B1/no not_active IP Right Cessation
- 2001-06-14 IL IL143775A patent/IL143775A/en not_active IP Right Cessation
- 2001-06-15 LV LVP-01-93A patent/LV12728B/en unknown
2006
- 2006-11-13 CY CY20061101634T patent/CY1106264T1/el unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5614205A (en)	1992-02-24	1997-03-25	Encelle, Inc.	Bioartificial endocrine device
US5569462A (en)	1993-09-24	1996-10-29	Baxter International Inc.	Methods for enhancing vascularization of implant devices
US5725854A (en)	1994-04-13	1998-03-10	Research Corporation Technologies, Inc.	Methods of treating disease using sertoli cells an allografts or xenografts

Also Published As

Publication number	Publication date
TR200101769T2 (tr)	2002-02-21
AU772166B2 (en)	2004-04-08
DE69932866D1 (de)	2006-09-28
HU226054B1 (en)	2008-04-28
PL352559A1 (en)	2003-08-25
DE69932866T2 (de)	2007-03-29
CN1204854C (zh)	2005-06-08
NO318469B1 (no)	2005-03-21
EP1435220B1 (en)	2006-08-16
PT1435220E (pt)	2006-12-29
LV12728B (en)	2001-12-20
EA003119B1 (ru)	2003-02-27
IS5968A (is)	2001-06-14
CZ20012158A3 (cs)	2002-01-16
CN1330529A (zh)	2002-01-09
KR20020015679A (ko)	2002-02-28
CZ302458B6 (cs)	2011-06-01
SI20847B (sl)	2009-04-30
CA2355675C (en)	2006-07-04
SI20847A (sl)	2002-10-31
LV12728A (en)	2001-10-20
CA2355675A1 (en)	2000-06-22
EE200100325A (et)	2002-12-16
PL191994B1 (pl)	2006-08-31
IL143775A (en)	2006-09-05
DK1435220T3 (da)	2006-12-11
RO120313B1 (ro)	2005-12-30
KR100502285B1 (ko)	2005-07-20
SK285392B6 (sk)	2006-12-07
ATE336207T1 (de)	2006-09-15
AU1805700A (en)	2000-07-03
JP3722698B2 (ja)	2005-11-30
HUP0203247A2 (en)	2003-01-28
ES2270626T3 (es)	2007-04-01
EA200100664A1 (ru)	2001-12-24
NO20012942L (no)	2001-08-07
CY1106264T1 (el)	2011-10-12
US6716246B1 (en)	2004-04-06
EP1435220A2 (en)	2004-07-07
IS2351B (is)	2008-04-15
IL143775A0 (en)	2002-04-21
EP1435220A4 (fr)	2005-03-02
NZ512358A (en)	2004-12-24
EE04802B1 (et)	2007-04-16
NO20012942D0 (no)	2001-06-14
BR9917048A (pt)	2002-04-02
HK1067295A1 (en)	2005-04-08
LT2001062A (en)	2003-01-27
WO2000035371A3 (es)	2004-05-06
SK8292001A3 (en)	2001-12-03
WO2000035371A2 (es)	2000-06-22
JP2003524451A (ja)	2003-08-19

Publication	Publication Date	Title
LT5015B (lt)	2003-04-25	Biologinės medžiagos implantavimo palengvinimo įtaisas
US4378016A (en)	1983-03-29	Artificial endocrine gland containing hormone-producing cells
US4402694A (en)	1983-09-06	Body cavity access device containing a hormone source
US5324518A (en)	1994-06-28	Implantable structure for containing substances for delivery to a body
JPH06505186A (ja)	1994-06-16	脊髄液駆動式人工器官
JP2005502426A5 (xx)	2006-01-05
CN1129402A (zh)	1996-08-21	密封可植入的薄膜封装件的方法和装置
WO1991000119A1 (en)	1991-01-10	Implantable device
NO300488B1 (no)	1997-06-09	Neurologisk behandlingsanordning
An et al.	2019	An atmosphere‐breathing refillable biphasic device for cell replacement therapy
KR20190086489A (ko)	2019-07-22	피하 임플란트와 함께 이용하기에 적합한 경피 가스 확산 장치
EP0120061A1 (en)	1984-10-03	Encapsulated genetically programmed living organisms producing therapeutic substances
Kobayashi	2008	Bioartificial pancreas for the treatment of diabetes
US20140154299A1 (en)	2014-06-05	Flat device for facilitating the transplant of biological material
HK1067295B (en)	2006-12-22	Process and device for facilitating the implantation of biological material
MXPA98010667A (es)	2000-06-01	Procedimiento y dispositivo para favorecer el implante de material biologico
KR20220128643A (ko)	2022-09-21	세포 전달 물품 및 투여 방법

Legal Events

Date	Code	Title	Description
2017-07-10	MM9A	Lapsed patents	Effective date: 20161214